152 related articles for article (PubMed ID: 26445115)
21. Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: A narrative review.
Frey S; Mirallié É; Cariou B; Blanchard C
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):981-996. PubMed ID: 33612382
[TBL] [Abstract][Full Text] [Related]
22. Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial.
Ejlsmark-Svensson H; Rolighed L; Rejnmark L
J Clin Endocrinol Metab; 2019 Aug; 104(8):3223-3232. PubMed ID: 30860588
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review.
Pepe J; Cipriani C; Sonato C; Raimo O; Biamonte F; Minisola S
Eur J Endocrinol; 2017 Dec; 177(6):R297-R308. PubMed ID: 28864535
[TBL] [Abstract][Full Text] [Related]
24. Primary hyperparathyroidism.
Walker MD; Silverberg SJ
Nat Rev Endocrinol; 2018 Feb; 14(2):115-125. PubMed ID: 28885621
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular Risk in Patients with Primary Hyperparathyroidism.
Tournis S; Makris K; Cavalier E; Trovas G
Curr Pharm Des; 2020; 26(43):5628-5636. PubMed ID: 33155899
[TBL] [Abstract][Full Text] [Related]
26. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
27. Hyperparathyroidism.
Bilezikian JP; Bandeira L; Khan A; Cusano NE
Lancet; 2018 Jan; 391(10116):168-178. PubMed ID: 28923463
[TBL] [Abstract][Full Text] [Related]
28. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up.
Stefenelli T; Abela C; Frank H; Koller-Strametz J; Globits S; Bergler-Klein J; Niederle B
J Clin Endocrinol Metab; 1997 Jan; 82(1):106-12. PubMed ID: 8989242
[TBL] [Abstract][Full Text] [Related]
29. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy.
Stefenelli T; Mayr H; Bergler-Klein J; Globits S; Woloszczuk W; Niederle B
Am J Med; 1993 Aug; 95(2):197-202. PubMed ID: 8356983
[TBL] [Abstract][Full Text] [Related]
30. Management of normocalcemic primary hyperparathyroidism.
Cusano NE; Cipriani C; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):837-845. PubMed ID: 30665550
[TBL] [Abstract][Full Text] [Related]
31. The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study.
Matzen J; Bislev LS; Sikjær T; Rolighed L; Hitz MF; Eiken P; Hermann AP; Jensen JB; Abrahamsen B; Rejnmark L
BMC Endocr Disord; 2022 Jan; 22(1):14. PubMed ID: 34991581
[TBL] [Abstract][Full Text] [Related]
32. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
33. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
[TBL] [Abstract][Full Text] [Related]
34. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.
Khan AA; Hanley DA; Rizzoli R; Bollerslev J; Young JE; Rejnmark L; Thakker R; D'Amour P; Paul T; Van Uum S; Shrayyef MZ; Goltzman D; Kaiser S; Cusano NE; Bouillon R; Mosekilde L; Kung AW; Rao SD; Bhadada SK; Clarke BL; Liu J; Duh Q; Lewiecki EM; Bandeira F; Eastell R; Marcocci C; Silverberg SJ; Udelsman R; Davison KS; Potts JT; Brandi ML; Bilezikian JP
Osteoporos Int; 2017 Jan; 28(1):1-19. PubMed ID: 27613721
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy.
Brener A; Cleper R; Baruch G; Rothschild E; Yackobovitch-Gavan M; Beer G; Zeitlin L; Kapusta L
Front Endocrinol (Lausanne); 2024; 15():1400273. PubMed ID: 38818505
[TBL] [Abstract][Full Text] [Related]
36. Improvement of hypertension control and left-ventricular function after cure of primary hyperparathyroidism.
Karwacka I; Kmieć P; Kaniuka-Jakubowska S; Pisowodzka I; Fijałkowski M; Sworczak K
Front Endocrinol (Lausanne); 2023; 14():1163877. PubMed ID: 37492200
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis.
Aguilar A; Gifre L; Ureña-Torres P; Carrillo-López N; Rodriguez-García M; Massó E; da Silva I; López-Báez V; Sánchez-Bayá M; Prior-Español Á; Urrutia M; Paul J; Bustos MC; Vila A; Garnica-León I; Navarro-González JF; Mateo L; Bover J
Front Physiol; 2023; 14():1177829. PubMed ID: 37342799
[TBL] [Abstract][Full Text] [Related]
38. Parathyroidectomy for adults with primary hyperparathyroidism.
Pappachan JM; Lahart IM; Viswanath AK; Borumandi F; Sodi R; Metzendorf MI; Bongaerts B
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013035. PubMed ID: 36883976
[TBL] [Abstract][Full Text] [Related]
39. Effect of Parathyroidectomy on Left Ventricular Mass Index in Patients With Primary Hyperparathyroidism.
Tzikos G; Doundoulakis I; Doutsini S; Adamidou F; Zafeiropoulos S; Koliastasis L; Manani C; Pliakos I; Papavramidis T
Cureus; 2023 Jan; 15(1):e33429. PubMed ID: 36751183
[TBL] [Abstract][Full Text] [Related]
40. Arterial Stiffness in Thyroid and Parathyroid Disease: A Review of Clinical Studies.
Grillo A; Barbato V; Antonello RM; Cola MF; Parati G; Salvi P; Fabris B; Bernardi S
J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
